Aprea Therapeutics earnings were -$13.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest APRE earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$3.2M, down 17.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APRE reported annual earnings of -$13.0M, with -9.3% growth.
What were Aprea Therapeutics's earnings last quarter?
Aprea Therapeutics (NASDAQ: APRE) reported Q2 2025 earnings per share (EPS) of -$0.53, up 8.62% year over year. Total APRE earnings for the quarter were -$3.24 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$0.58.
As of the last Aprea Therapeutics earnings report, Aprea Therapeutics is currently losing money. Aprea Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$13.85 million, a 7.13% increase year over year.
What was APRE's earnings growth in the past year?
As of Aprea Therapeutics's earnings date in Q3 2025, Aprea Therapeutics's earnings has grown year over year. APRE earnings in the past year totalled -$13.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.